meta-analysis | Q815382 |
scholarly article | Q13442814 |
P819 | ADS bibcode | 2013PLoSO...863677S |
P356 | DOI | 10.1371/JOURNAL.PONE.0063677 |
P932 | PMC publication ID | 3665786 |
P698 | PubMed publication ID | 23723992 |
P5875 | ResearchGate publication ID | 236978547 |
P50 | author | Isabelle Boutron | Q20090328 |
Philippe Ravaud | Q37368509 | ||
Ludovic Trinquart | Q37836849 | ||
P2093 | author name string | Valérie Seegers | |
P2860 | cites work | The challenges of clinical trials in the exclusion zone: the case of the frail elderly. | Q40057608 |
Impact of single centre status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological study | Q41111726 | ||
Including older people in clinical research | Q42671444 | ||
Balancing benefits and harms in health care. | Q42784217 | ||
Meta-analysis and the meta-epidemiology of clinical research | Q42785474 | ||
EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors | Q43793625 | ||
Interpretation of random effects meta-analyses. | Q43810883 | ||
Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines | Q44283416 | ||
Comparative effectiveness of medical interventions in adults versus children | Q44695978 | ||
The importance of allocation concealment and patient blinding in osteoarthritis trials: a meta-epidemiologic study | Q45073390 | ||
Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study | Q45228027 | ||
The quality of pharmacologic care for vulnerable older patients | Q46097111 | ||
Participation of patients 65 years of age or older in cancer clinical trials | Q48006693 | ||
A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials | Q52032770 | ||
Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research | Q52036957 | ||
Multivariable modelling for meta-epidemiological assessment of the association between trial quality and treatment effects estimated in randomized clinical trials | Q53013525 | ||
Disparate inclusion of older adults in clinical trials: priorities and opportunities for policy and practice change | Q53064501 | ||
Reporting of Safety Results in Published Reports of Randomized Controlled Trials | Q57286555 | ||
Improving the Quality of Medication Use in Elderly Patients | Q58071028 | ||
The Persistent Exclusion of Older Patients From Ongoing Clinical Trials Regarding Heart Failure | Q60723673 | ||
Quality of medical care delivered to Medicare beneficiaries: A profile at state and national levels | Q73031726 | ||
Underrepresentation of patients 65 years of age or older in cancer-treatment trials | Q73311140 | ||
Drug therapy in the elderly: improving quality and access | Q73356811 | ||
Can quality of clinical trials and meta-analyses be quantified? | Q77326667 | ||
Geriatric oncology aims for clinical trials | Q79319666 | ||
Age-based exclusions from cardiovascular clinical trials: implications for elderly individuals (and for all of us): comment on "the persistent exclusion of older patients from ongoing clinical trials regarding heart failure" | Q83737779 | ||
Why the exclusion of older people from clinical research must stop | Q84187295 | ||
Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies | Q24282604 | ||
Quality of Cochrane reviews: assessment of sample from 1998 | Q24555211 | ||
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials | Q27860509 | ||
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials | Q27860735 | ||
Meta-analysis in clinical trials | Q27860779 | ||
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators | Q28372091 | ||
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? | Q29619328 | ||
The hazards of scoring the quality of clinical trials for meta-analysis | Q29619369 | ||
Interaction revisited: the difference between two estimates | Q29619619 | ||
Comparison of evidence of treatment effects in randomized and nonrandomized studies | Q30699759 | ||
What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data | Q30926358 | ||
Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials | Q33285346 | ||
Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview | Q33894784 | ||
Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas | Q33937374 | ||
Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs | Q34221473 | ||
Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review | Q34610692 | ||
Representation of the elderly, women, and minorities in heart failure clinical trials | Q34769936 | ||
Improving medication use for older adults: an integrated research agenda | Q35215906 | ||
The exclusion of the elderly and women from clinical trials in acute myocardial infarction | Q35765397 | ||
Cautionary tales in the interpretation of clinical studies involving older persons | Q37729624 | ||
Improving recruitment of older people to research through good practice | Q37930797 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pharmacology | Q128406 |
P304 | page(s) | e63677 | |
P577 | publication date | 2013-01-01 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Comparison of treatment effect estimates for pharmacological randomized controlled trials enrolling older adults only and those including adults: a meta-epidemiological study | |
P478 | volume | 8 |
Q38343604 | Drug therapies in older adults (part 1). | cites work | P2860 |
Search more.